SCHEMBL19919793

SCHEMBL19919793

N#Cc1cc(-n2c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)cc1-n1c2ccc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)cc2c2cc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.37
ALOX5AP P20292 2/20 0.36
FEN1 P39748 2/20 0.36
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HPGD P15428 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
GAA P10253 1/20 0.35
XDH P47989 1/20 0.34
CYP2C9 P11712 1/20 0.34
SCN9A Q15858 1/20 0.34
CTSK P43235 3/20 0.33
CTSS P25774 2/20 0.33
PGR P06401 1/20 0.33
TOP1 P11387 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP11B1 P15538 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22021221 0.98 AR (0.36) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19919653 0.94 AR (0.35) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19909404 0.94 ALOX5AP (0.38) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19919797 0.93 ALOX5AP (0.36) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19919642 0.93 AR (0.36) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19913259 0.93 AR (0.37) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL23487289 0.91 AR (0.36) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19919632 0.91 CTSS (0.36) ALOX5APFEN1KDM4EALDH1A1L3MBTL1
SCHEMBL19913250 0.89 AR (0.38) ARALOX5APFEN1KDM4EALDH1A1
SCHEMBL19909517 0.89 KIF11 (0.35) ALOX5APFEN1KDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 AR 4444/4885ALOX5AP 3906/4885FEN1 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.